Reuters logo
3 个月前
BRIEF-Biopharmx says achieved primary endpoint in trial of treatment for acne
2017年5月3日 / 晚上9点35分 / 3 个月前

BRIEF-Biopharmx says achieved primary endpoint in trial of treatment for acne

1 分钟阅读

May 3 (Reuters) - Biopharmx Corp

* Biopharmx Corp says achieved primary endpoint in its phase 2b clinical trial evaluating bpx-01

* Biopharmx Corp says based on these phase 2b results, Biopharmx continues to progress bpx-01 towards a phase 3 program Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below